Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Roche”
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Relapsed /Refractory DLBCL
Germany
Sponsor: Hansoh BioMedical R&D Company
Solid Tumors
United States, China
Sponsor: Incyte Corporation
NSCLC (Non-small Cell Lung Carcinoma) · UC (Urothelial Cancer)
United States
Sponsor: Heidelberg University
Stage II Grade 1 Follicular Lymphoma · Stage II Grade 2 Follicular Lymphoma · Stage I Follicular Lymphoma Grade 1 · Stage II Follicular Lymphoma Grade 2
Germany
- Outcomes From Point-of-Care Sexually Transmitted Infection (STI) Testing in an Urban Sexual Health Clinic: A Randomized TrialNot Yet Recruiting
Sponsor: Massachusetts General Hospital
Neisseria Gonorrhoeae Infection · Chlamydia Trachomatis Infection
Sponsor: Hoffmann-La Roche
Uveitic Macular Edema
United States, Argentina, Australia, China, Czechia +14 more
Sponsor: Carmot Therapeutics, Inc.
Obesity · Overweight
United States
- Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled TrialActive Not Recruiting
Sponsor: McMaster University
Diabetic Macular Edema
United States, Australia, Canada, United Kingdom
- The GOLD Study: G8 in OLDer PatientsActive Not Recruiting
Sponsor: Istituto Oncologico Veneto IRCCS
Elderly Metastatic Colorectal Cancer Patients
Italy
Sponsor: Hoffmann-La Roche
Gastric and Gastroesophageal Junction Carcinoma
China
- A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During PregnancyCompleted
Sponsor: Hoffmann-La Roche
Multiple Sclerosis · Clinically Isolated Syndrome
United States, France, Germany, Spain, Switzerland
- A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the LungActive Not Recruiting
Sponsor: Technische Universität Dresden
Large Cell Neuroendocrine Carcinoma of the Lung
Germany
- Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA SuppressionActive Not Recruiting
Sponsor: Royal Marsden NHS Foundation Trust
Metastatic Breast Cancer · ER+ Breast Cancer · Advanced Breast Cancer
United Kingdom
Sponsor: Hoffmann-La Roche
Multiple Myeloma
Australia, Belgium, Denmark, France, Italy +4 more
- Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase InhibitorActive Not Recruiting
Sponsor: Canadian Cancer Trials Group
Breast Cancer
Australia, Canada, New Zealand
Sponsor: Hoffmann-La Roche
Esophageal Cancer
China, Hong Kong, South Korea, Taiwan, Thailand
- Tocilizumab Treatment in Patients With COVID-19Active Not Recruiting
Sponsor: Instituto Nacional de Cancerologia de Mexico
Sars-CoV2
Mexico
Sponsor: AbbVie
Acute Myeloid Leukemia (AML)
United States, Australia, Canada, China, Czechia +14 more
- Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOPActive Not Recruiting
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Lymphoma, Large B-Cell, Diffuse
Austria, Germany
Sponsor: Spanish Breast Cancer Research Group
Breast Neoplasms
Spain
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
HIV Infections · AIDS
France
Sponsor: ANRS, Emerging Infectious Diseases
Hepatitis
France
Sponsor: Hoffmann-La Roche
Small Cell Lung Cancer
United States, Australia, Austria, Belgium, Brazil +18 more
Sponsor: Hoffmann-La Roche
Diabetic Retinopathy
United States, Puerto Rico
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
HIV Infections
France